Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Statera Biopharma Inc STAB

Healthcare Biotechnology
Statera BioPharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing immunotherapies autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis. It has platform of toll-like receptor (TLR) agonists with TLR4 and TLR9 antagonists, and the TLR5 agonists... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:STAB)

Statera Biopharma Signs Letter of Intent for Merger with Worksite Labs

GlobeNewswire March 15, 2023

Statera Biopharma Announces Completion of Application Process to Uplist to the OTCQB(R) Venture Marketplace

Accesswire January 24, 2023

Statera Biopharma Receives Positive Nasdaq Listing Determination

Accesswire October 27, 2022

Statera Biopharma Files Form 10-Q and Reaches Agreement with Silverback Capital and AVOF

Accesswire October 21, 2022

Statera Biopharma Announces Signing of a Binding MOU with Holobeam Technologies to Gain Access to Holobeam's Disruptive Diagnostic Imaging and Therapeutic Technology for Cancer Patients

Accesswire October 17, 2022

Statera Biopharma Completes Fiscal 2021 Audit; Files Form 10-K

Accesswire October 6, 2022

Statera Biopharma Receives Nasdaq Listing Determination; Hearing Requested to Address Filing Delinquency

Accesswire September 9, 2022

Nasdaq Resumes Trading in Statera Biopharma, Inc.

GlobeNewswire August 26, 2022

Statera Biopharma Receives Anticipated Notice of Additional Filing Delinquency from Nasdaq

Accesswire August 25, 2022
View More News ››

Opinion & Analysis (GREY:STAB)

No current opinion is available.
View More Opinion ››

Bullboard Posts (GREY:STAB)

5 years later

Going to look at this in 5 years,  bought in at .30 cents 105000 shares  wish me luck   
Daddysgotthis - May 11, 2022

Lets hope tomorrow

is a better day!  I am actually shocked of the market reaction today. 
craighenry - January 23, 2014

undervalued?

What is going on with this company? Seems grossly udervalued with a few strong buy recommendations...
ruben12345 - December 18, 2013

Buffalo Facility Appears State of the Art

Saw this comment on another message board………The blogger commented on Gudkov's Buffalo lab and facilities as being state of the art. ...
DallasTaurus - July 6, 2007

Shares Headed North Today

Shares Were Up Strong after the Holiday; Heading North 4.59 Percent Thursday. I recently noticed some informational Q and A points on...
DallasTaurus - July 6, 2007

Value Rich Coverage

Cleveland BioLabs is featured on Value Rich (iValueRich.com) and the Spring 2007 Issue of Value Rich Magazine The article notes...
DallasTaurus - July 3, 2007
View more Bullboard ››

Tenet Fintech Group Inc.

Tenet Fintech Group Inc.

Tenet Fintech Group Inc. is the parent company of a group of innovative financial technology (Fintech) and artificial ...
View More »